The table below shows Eterna Therapeutics Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
$582.00K
$68.00K
$0.00
-
$5.80M
Cost of revenue
-
$96.00K
$236.00K
$0.00
-
-
Gross profit
-
$486.00K
-$168.00K
$0.00
-
-
R&D
-
-
-
-
-
$2.00K
SG&A
-
ERNA annual revenue (10-K history)
Eterna Therapeutics Inc. reported annual revenue of $582.00K for fiscal year 2024. That is up 755.9% from $68.00K in fiscal 2023. Over the 10 fiscal years shown, annual revenue declined from $26.05M (FY 2014) to $582.00K. Figures come from the company's audited annual reports as filed with the SEC.